Protagonist Therapeutics, Inc.
PTGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $114 | $169 | $140 | $97 |
| Short-Term Investments | $462 | $402 | $435 | $322 |
| Receivables | $1 | $28 | $27 | $168 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $10 | $4 | $4 | $4 |
| Total Curr. Assets | $586 | $603 | $606 | $592 |
| Property Plant & Equip (Net) | $12 | $13 | $13 | $13 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $103 | $102 | $124 | $140 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $115 | $115 | $136 | $153 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $702 | $718 | $742 | $745 |
| Liabilities | – | – | – | – |
| Payables | $6 | $3 | $3 | $2 |
| Short-Term Debt | $2 | $2 | $2 | $1 |
| Tax Payable | $0 | $0 | $2 | $3 |
| Deferred Revenue | $0 | $15 | $17 | $19 |
| Other Curr. Liab. | $37 | $15 | $12 | $24 |
| Total Curr. Liab. | $45 | $36 | $35 | $47 |
| LT Debt | $9 | $9 | $10 | $10 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $5 | $8 | $12 |
| Total NC Liab. | $11 | $14 | $18 | $22 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $11 | $11 | $11 | $11 |
| Total Liabilities | $56 | $50 | $53 | $69 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$426 | -$387 | -$352 | -$341 |
| AOCI | $1 | -$0 | $0 | -$0 |
| Other Equity | $1,071 | $1,055 | $1,041 | $1,016 |
| Total Equity | $645 | $668 | $689 | $675 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $702 | $718 | $742 | $745 |
| Net Debt | -$103 | -$157 | -$128 | -$86 |